DETERMINATION SYSTEM FOR DETERMINING A HEART FAILURE RISK

Patent №

US 11,337,659

Granted

2022-05-24

Filed 2018

Owner

KONINKLIJKE PHILIPS N.V.

Lab

AI components

1

kr

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

16072661

The invention relates to a determination system for determining a heart failure risk for a subject (4). The determination system (1) comprises a photoplethysmogram providing unit for providing a photoplethysmogram of the subject and a heart failure risk determination unit for determining the heart failure risk based on the provided photoplethysmogram. A photoplethysmogram can be provided in an unobtrusive way by using a photoplethysmogram sensor without requiring a physician's attendance. In particular, it is not necessarily required to measure electrocardiograms, to carry out blood tests and to perform a coronary angiography for determining the heart failure risk. The heart failure risk can therefore be determined in a technically relatively simple way without requiring a physician's attendance.

Knowledge representationA61B 5/7275A61B 5/02116A61B 5/02416A61B 5/1118A61B 5/14551A61B 5/681A61B 5/7278G16H 40/63+3 more

AI classification

Knowledge representation0.63
Evolutionary computation0.04
Vision0.04
AI hardware0.01
Machine learning0.00
Natural language0.00
Speech0.00
Planning0.00

Ownership

KONINKLIJKE PHILIPS N.V.

assignment · 464570152

Assignors

AARTS, RONALDUS MARIA

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC